Skip to main content
Tech.euFundingExplorerBeta

Focus-X Therapeutics

Exited

Preclinical stage biotechnology company committed to the discovery and development of cutting-edge radiopharmaceuticals.

Focus-X Therapeutics is tracked in the Tech.eu funding database. Based in New Jersey, United States; active in Healthtech. Acquired by Full-Life Technologies in 2022. Data as of Nov 2026.

Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Nov 2022
Value
€237M
Acquiror
Full-Life Technologies (Belgium)

Similar companies

same sector, similar size

Global coverage: FundingData